Literature DB >> 3931060

Management of streptococcal pharyngitis reconsidered.

M A Gerber, M Markowitz.   

Abstract

Adequate treatment of GABHS pharyngitis with penicillin shortens the course of illness, reduces the spread of streptococci and prevents suppurative complications. It has also been a major factor in the markedly accelerated decline in the incidence of acute rheumatic fever in this country. Difficulties in the clinical diagnosis of GABHS pharyngitis make bacteriologic confirmation highly desirable. Currently a properly performed throat culture is the best way to obtain this bacteriologic confirmation. However, it is possible that rapid antigen detection tests will replace the throat culture in the future. These diagnostic tools should be used more selectively and only in conjunction with clinical and epidemiologic data. Greater selectivity will help control costs and will increase the chances of identifying patients who are truly infected and are not merely streptococcal carriers. Penicillin is still the drug of choice and an oral preparation given twice daily is as effective as more frequent doses. Patients at risk for noncompliance should be treated with a single injection of benzathine penicillin combined with procaine penicillin to lessen the local discomfort. Routine follow-up cultures of asymptomatic patients should be abandoned. Persistence of GABHS following a course of treatment may no longer be an important risk factor for the development of rheumatic fever. However, there are exceptional cases, as noted in the text, in which eradication of GABHS carriage with a short course of rifampicin may be desirable.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931060     DOI: 10.1097/00006454-198509000-00016

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  8 in total

Review 1.  How effective are treatments other than antibiotics for acute sore throat?

Authors:  M Thomas; C Del Mar; P Glasziou
Journal:  Br J Gen Pract       Date:  2000-10       Impact factor: 5.386

2.  Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice.

Authors:  C F Dagnelie; Y van der Graaf; R A De Melker
Journal:  Br J Gen Pract       Date:  1996-10       Impact factor: 5.386

3.  Management of streptococcal pharyngitis.

Authors:  S Chaudhary
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

Review 4.  Group A Streptococcus: a re-emergent pathogen. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1993-06-01       Impact factor: 8.262

5.  A comparison of cefadroxil and penicillin V in the treatment of streptococcal pharyngitis in children.

Authors:  M A Gerber
Journal:  Drugs       Date:  1986       Impact factor: 9.546

6.  Benzathine penicillin G for rheumatic fever prophylaxis: 2-weekly versus 4-weekly regimens.

Authors:  A S Kassem; A A Madkour; B Z Massoud; S R Zaher
Journal:  Indian J Pediatr       Date:  1992 Nov-Dec       Impact factor: 1.967

Review 7.  Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.

Authors:  J M McCarty
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-10       Impact factor: 3.267

Review 8.  [Patient consent to "antimicrobial treatment of tonsillitis"].

Authors:  C Cenjor; J A García-Rodríguez; A Ramos; J Cervera; M Tomás; F Asensi; J L Cañada; M Gobernado; T Isasiá; C López-Madroñero; M Martínez; F Pérez-Escanilla; J Picazo; J Prieto; T Sampelayo
Journal:  Acta Otorrinolaringol Esp       Date:  2003-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.